Informed choice to undergo prenatal screening for thalassemia: A description of written information given to pregnant women in Europe and beyond

Prenatal Diagnosis

Volumn 28, Issue 8, 2008, Pages 727-734

  Van Den Heuvel, Ananda ^a   Hollywood, Amelia ^b   Hogg, Julie ^c   Dormandy, Elizabeth ^a   Chitty, Lyn ^d   Kabra, Madhulika ^e   Ma, Runmei ^f   Masturzo, Bianca ^g   Marteau, Theresa M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^f KUNMING MEDICAL UNIVERSITY   (China)

^g Sant'Anna Hospital   (Italy)

Author keywords

Informed choice; Patient education; Prenatal diagnosis; Thalassemia

Indexed keywords

ARTICLE; CHINA; CLINICAL EVALUATION; EUROPE; GREECE; HUMAN; INDIA; INFORMATION PROCESSING; ISRAEL; ITALY; MEDICAL INFORMATION; NETHERLANDS; PREGNANT WOMAN; PRENATAL SCREENING; PRIORITY JOURNAL; THALASSEMIA; UNITED KINGDOM;

ASIA; CHOICE BEHAVIOR; CONSUMER HEALTH INFORMATION; EUROPE; FEMALE; HUMANS; INFORMED CONSENT; MASS SCREENING; PREGNANCY; PRENATAL DIAGNOSIS; THALASSEMIA;

EID: 49949085966     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1995     Document Type: Article

References (30)

1. Armstrong T, Swartzman L. 2001. Cross cultural differences in Illness Models and Expectations for the Health Care Provider-Client/Patient Interaction. In Handbook of Cultural Health Psychology, Kazarian S, Evans D (eds). Academic Press: San Diego, CA; 63-84.
2. Baker H, Crockett R, Uus K, Bamford J, Marteau T. 2007. Why don't health professionals check patient understanding? Psychol Health Med 12(3): 380-385.
3. Barrett A. 2005. NHS publicises advances in antenatal and neonatal screening programmes. BMJ 331: 180.
4. Braddock C, Edwards K, Hasenberg N, Laidley T, Levinson W. 1999. Informed decision making in outpatient practice - time to get back to basics. J Am Med Assoc 282: 2313-2320.
5. Bryant LD, Murray J, Green JM, Hewison J, Sehmiw I, Ellis A. 2001. Descriptive information about Down's syndrome: a content analysis of serum screening leaflets. Prenat Diagn 21: 1057-1063.
6. Champion P, Foulkes J, Neighbour R, Tate P. 2002. Patient centred-ness in the MRCGP video examination: analysis of large cohort. BMJ 325: 691-692.
7. Charnock D, Shepperd S, Needham G, Gann R. 1999. DISCERN: an instrument for judging the quality of written consumer health information on treatment choices. J Epidemiol Community Health 53: 105-111.
8. Dormandy E, Marteau TM. 2004. Uptake of an antenatal screening test: the role of healthcare professionals' attitudes towards the test. Prenat Diagn 24: 864-868.
9. Dormandy E, Michie S, Weinman J, Marteau TM. 2002. Variation in uptake of serum screening: the role of service delivery. Prenat Diagn 22: 67-69.
10. Edwards A, Elwyn G. 2001. Understanding risk and lessons for clinical risk communication about treatment preferences. Qual Health Care 10(Suppl. I): i9-i13.
11. Farsides B, Williams C, Alderson P. 2004. Aiming towards 'moral equilibrium': health care professionals' views on working within the morally contested field of antenatal screening. J Med Ethics 30: 505-509.
12. Figueiras M, Price H, Marteau TM. 1999. Effects of textual and pictorial information upon perceptions of Down syndrome: an analogue study. Psychol Health 14: 761-771.
13. Flaherty JA, Gaviria M, Pathak D, et al. 1988. Developing instruments for cross-cultural psychiatric research. J Nerv Ment Dis 176: 257-263.
14. Fox R. 2006. Informed choice in screening programmes: do leaflets help? A critical literature review. J Public Health 28: 309-317.
15. Giordano PC, Plancke A, Van Meir C, et al. 2006. Carrier diagnostics and prevention of hemoglobinopathies in early pregnancy in The Netherlands: a pilot study. Prenat Diagn 26: 719-724.
16. Hall S, Abramsky L, Marteau TM. 2003. Health professionals' reports of information given to parents following the prenatal diagnosis of sex chromosome anomalies and outcomes of pregnancies: a pilot study. Prenat Diagn 23: 535-538.
17. Hall S, Chitty L, Dormandy E, et al. 2007. Undergoing prenatal screening for Down's syndrome: presentation of choice and information in Europe and Asia. Eur J Hum Genet 15: 363-369.
18. Hargreaves K, Stewart R, Oliver S. 2005. Informed choice and public health screening for children: the case of blood spot screening. Health Expect 8: 161-171.
19. Hofstede G. 2001. Culture's Consequences. Sage Publications: London.
20. Jafarey A, Farooqui A. 2005. Informed consent in the Pakistani milieu: the physician's perspective. J Med Ethics 30: 93-96.
21. Ley P. 1988. Communicating with patients. Improving Communication, Satisfaction and Compliance. Croom Helm Ltd: London.
22. Liao C, Mo O, Li J, et al. 2005. Carrier screening for α- and β -thalassemia in pregnancy: the results of an 11-year prospective program in Guangzhou Maternal and Neonatal hospital. Prenat Diagn 25: 163-171.
23. Loeben G, Marteau TM, Wilfond B. 1998. Mixed messages: presentation of information in cystic fibrosis screening pamphlets. Am J Hum Genet 63: 1181-1189.
24. Mao X. 1998. Chinese geneticists' views of ethical issues in genetic testing and screening: evidence for eugenics in China. Am J Hum Genet 63: 518-522.
25. Marteau TM, Dormandy E, Michie S. 2001. A measure of informed choice. Health Expect 4: 99-108.
26. National Screening Committee. 2002. Second Report of the National Screening Committee. Department of Health: London, http://www.nsc.nhs.uk/ pdfs/secondreport.pdf [19 June 2008].
27. O'Connor AM, Stacey D, Entwistle V, et al. 2003. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev (2): CD001431.
28. Public and Professional Screening Committee. 2000. Population genetic screening programmes: proposed recommendations of the European society of human genetics. Eur J Hum Genet 8: 998-1000.
29. Van den Berg M, Timmermans D, Kleinveld J, Garcia E, Van Vugt J, Van der Wal G. 2005. Accepting or declining the offer of prenatal screening for congenital defects: test uptake and women's reasons. Prenat Diagn 25: 84-90.
30. World Health Organisation. 2006. Thalassaemia and other haemoglobinopathies.